News & Perspective

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Jul 17, 2008

Jul 17, 2008

GAO looks abroad for food-safety oversight lessons

(CIDRAP News) – The Government Accountability Office (GAO) recently released a report examining the results several developed nations and the European Union achieved when they consolidated oversight of food safety in a single agency, a step often advocated in the United State for solving some of the problems linked to contaminated imported and domestic food.

Apr 16, 2008

Apr 16, 2008

Study: New seasonal flu strains launch from Asia

(CIDRAP News) – Seasonal influenza viruses flow out of overlapping epidemics in East and Southeast Asia, then trickle around the globe before dying off, researchers from the World Health Organization (WHO) committee that selects the viral strains for the annual flu vaccine said today.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»